Modeling Decision Processes in Veterinary Healthcare
World Small Animal Veterinary Association World Congress Proceedings, 2003
Lloyd Reeve-Johnson, DVM&S, CertBA, PhD, DECVPT, FIbiol, FRCVS
Petdoctors Ltd.
Chandlers Ford, Hampshire, UK

Objectives

To produce a model of the sequence of veterinary healthcare decisions to better understand the interplay between each participant (patient/client/clinician/innovator/regulator/dispenser) and understand how this process can be influenced.

Method

Information was sourced from our practice database of over 250,000 veterinary healthcare transactions annually in 22 clinics utilizing the major animal health suppliers in our market, insurance companies, 50 primary-care veterinary clinicians and referral specialists, surveys of owners and para-veterinary professionals and personal interviews with researchers and managers in Animal Health and Veterinary Wholesale companies.

Results

Six types of participant were identified as active in any healthcare process. Namely: patient/owners, payers, influencers, innovators, regulators and dispensers. Each of these perceived the value of healthcare services differently. The core activity around which all the participants revolved was the decision to seek treatment for either a real or perceived illness, or to promote health. Without this action, nothing else would occur. The process was broken into component parts (identifying a need, seeking treatment, diagnosis, establishing a treatment plan, supply of product or service and re-evaluation, where lifestyle and funding heavily influenced overall compliance with the regime). This occurs in all markets.

Conclusions

Provision of healthcare is fundamentally a transaction and is the mechanism by which the participants in healthcare interact and rationalize their perspectives of value into a common economic exchange. Points of influence can be used to alter the type of healthcare intervention utilized by the market. From a strategic planning perspective, these can be used to target market niches where adoption would be most rapid for new products.

Reference

1.  Reeve-Johnson, L. (2002) Quantifying and maximizing the value of innovation in the pharmaceutical industry (MBA thesis-under review). Edinburgh Business School.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Lloyd Reeve-Johnson, DVM&S, CertBA, PhD, DECVPT, FIbiol, FRCVS
Petdoctors Ltd.
Chandlers Ford, Hampshire, UK


MAIN : Alternative Medicine : Modeling Decision Processes
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27